Surgery Partners (SGRY) Stock: $51 Price Target From Stifel

By Amit Chowdhry ● Nov 29, 2021
  • The shares of Surgery Partners Inc (NASDAQ: SGRY) have received a price target of $51 from Stifel. These are the details.

The shares of Surgery Partners Inc (NASDAQ: SGRY) have received a price target of $51 from Stifel. And Stifel analyst Tao Qiu upgraded Surgery Partners to a “Buy” rating from a “Hold” rating.

Qiu noted that Surgery Partners’ third quarter results proved the resilience of its business despite revenue disruptions and labor challenges from the surge in COVID-19 cases — who views the market selloff that drove shares 5% lower on Friday as a “Black Friday” deal. And Qiu believes the secular trend of surgical procedures moving to outpatient settings is accelerating and that Surgery Partners management has positioned the company to capitalize on this growth.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.